In this week's Homerun Slides, the conclusion of comparing Flash CGM with Dexcom rtCGM.Read More »
Production Assistant, Diabetes In Control
International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #153: Monogenic Disorders of the Beta Cell Part 3
Glucokinase MODY: Glucokinase catalyzes the phosphorylation of glucose to glucose-6-phosphate. Its unique kinetic properties result in the rate of glucose phosphorylation being proportional to the physiologic glucose concentration. This means that the beta cell and hepatocyte can respond appropriately to fluctuations in the degree of glycemia. In the pancreatic beta cell, glucokinase acts as “the glucose sensor” ensuring insulin release is appropriate to the blood glucose concentration.Read More »
The beta-cell preserving properties of short courses of metformin and insulin glargine evaluated in ever-growing population of patients who have diabetes.Read More »
Study assesses effect of new add-on therapy.Read More »
Can canagliflozin affect the progression of kidney disease in patients with type 2 diabetes?Read More »
The intestinal microbiota in people with type 1 and those with MODY2 differs in abundance and type compared to people without.Read More »
Infection risk is high among people with diabetes, but can better glycemic management improve lower infection risk?Read More »
Patients with either painful or painless neuropathy found to have low vitamin D levels.Read More »
When pricing for CGM systems comes down to less than using a blood glucose monitor with strips, will you recommend these to your patients who do not take insulin?
- For my patients who are motivated
- For my patients who are not motivated
Follow the link to see how you and your colleagues compare.Read More »
Which of the following is accurate regarding the treatment and management of hypertriglyceridemia?
A. Pharmacologic therapy is typically initiated before lifestyle modifications in the treatment of primary and secondary dyslipidemia.
B. Patients can be treated before hypertriglyceridemia is confirmed.
C. Niacin raises LDL cholesterol levels.
D. High-potency statin monotherapy is recommended for severe or very severe hypertriglyceridemia.
Follow the link for the answer.Read More »